Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Inventory (2016 - 2025)

Historic Inventory for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $205.4 million.

  • Bio-Techne's Inventory rose 906.39% to $205.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $205.4 million, marking a year-over-year increase of 906.39%. This contributed to the annual value of $189.4 million for FY2025, which is 540.53% up from last year.
  • Per Bio-Techne's latest filing, its Inventory stood at $205.4 million for Q4 2025, which was up 906.39% from $203.2 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Inventory peaked at $205.4 million during Q4 2025, and registered a low of $110.0 million during Q1 2021.
  • Its 5-year average for Inventory is $163.8 million, with a median of $175.6 million in 2023.
  • Its Inventory has fluctuated over the past 5 years, first skyrocketed by 3210.17% in 2023, then tumbled by 55.84% in 2024.
  • Bio-Techne's Inventory (Quarter) stood at $121.9 million in 2021, then surged by 31.49% to $160.2 million in 2022, then rose by 12.86% to $180.8 million in 2023, then increased by 4.17% to $188.4 million in 2024, then increased by 9.06% to $205.4 million in 2025.
  • Its last three reported values are $205.4 million in Q4 2025, $203.2 million for Q3 2025, and $189.4 million during Q2 2025.